List of Oncology Medication For

Lung Cancer

The most commonly diagnosed type of lung cancer is carcinoma. There are many types of carcinoma-derived lung cancers, but the significant types are classified as small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). SCLC and NSCLC are the second cancer leaders. In comparison to NSCLC, SCLC can proliferate and form solid tumor masses more rapidly. In contrast with this highly proliferative potential, SCLC is known to be less aggressive than non-small lung malignancies.

If Lung Cancer Medicines are not yet approved or available in your area, you may give a request, to get access price in India under a specific brand name through IPN. For assistance and guidance, you can contact us by providing complete details. Our pharmaceutical expert will help you find a suitable and practical solution to your query. To receive comprehensive support, please call us at +91 9891 296 838 (Mr. Tarun) / +91 9811 747 774 (Mr. Neeraj).

ORKAMBI (lumacaftor/ivacaftor) tablets

Lung Cancer

ORKAMBI (lumacaftor/ivacaftor) tablets

ORKAMBI is a combination of lumacaftor and ivacaftor, a cystic fibrosis transmembrane conductance regulator (CFTR) potentiator, indicated for the treatment of cystic fibrosis (CF) in patients age 2 years and older who are homozygous for the F508del mutation in the CFTR gene. If the patient’s genotype is unknown, an FDA-cleared CF mutation test should be used to detect the presence of the F508del mutation on both alleles of the CFTR gene.

Brand Name:	ORKAMBI
Generic Name:	lumacaftor/ivacaftor
Strength:	• Tablets: lumacaftor 100 mg and ivacaftor 125 mg; lumacaftor 200 mg and ivacaftor 125 mg. • Oral granules: Unit-dose packets of lumacaftor 75 mg and ivacaftor 94 mg; lumacaftor 100 mg and ivacaftor 125 mg; lumacaftor 150 mg and ivacaftor 188 mg.
Manufacturer:	Vertex Pharmaceuticals
Approved By:	EMA, USFDA

Source Details: Patient Information

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import ORKAMBI (lumacaftor/ivacaftor) tablets” based on the information you provide.

Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India. With over two decades of industry experience, IPN offers extensive coverage across India, including prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

osimertinib tablet

Lung Cancer

osimertinib tablet
for oral use Initial U.S. Approval: 2015

Tagrisso (osimertinib) is a medicine for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) with a T790M mutation in the epidermal growth factor receptor (EGFR) gene.

Facts about osimertinib tablet

DISEASE INDICATIONS- non-small cell lung cancer
MANUFACTURER-AstraZeneca AB
USAGE-Oral Tablets: 80 mg and 40 mg
MEDICINE APPROVED BY-European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “osimertinib tablet” based on the information you provide.

paclitaxel injection

Breast Cancer, Lung Cancer, Ovarian

paclitaxel protein-bound particles for injectable suspension) (albumin-bound) for intravenous use Initial U.S. Approval: 2005

paclitaxel injection is a prescription medicine used to treat some forms of: • ovarian cancer • breast cancer • lung cancer • Kaposi’s sarcoma It is not known if TAXOL is safe or effective in children.

Facts about paclitaxel injection

Approval Date: 2005
Proprietary Name: On Request
Active Ingredient(s): paclitaxel injection
Dosage Forms And Strengths: For injectable suspension: white to yellow, sterile, lyophilized powder containing 100 mg of paclitaxel formulated as albumin-bound particles in single-dose vial for reconstitution.
Current indications: • ovarian cancer • breast cancer • lung cancer • Kaposi’s sarcoma
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import paclitaxel injection” based on the information you provide.

PALIVIZUMAB Injection

Lung Cancer

Palivizumab injection, for intramuscular use Initial U.S. Approval: 1998

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import PALIVIZUMAB Injection” based on the information you provide.

Pembrolizumab Injection

Kidney, Breast Cancer, Gastrointestinal, Lung Cancer, Lymphoma, Skin

Brand Name: Keytruda. Generic Name: pembrolizumab
Keytruda (pembrolizumab) is used to treat Urothelial Carcinoma, Breast Cancer, Colorectal Cancer, Gastric Cancer, Head and Neck Cancer, Kidney Cancer, Lung Cancer, Lymphoma, Skin Cancer

Facts about pembrolizumab injection

USAGE-intravenous
MEDICINE APPROVED BY- European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Initial U.S. Approval: 2014
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “pembrolizumab injection” based on the information you provide.

Pemrydi RTU (pemetrexed disodium) injection

Lung Cancer

Brand Name: Pemrydi RTU Generic Name: pemetrexed disodium Pemrydi RTU (pemetrexed disodium) is used to treat malignant pleural mesothelioma and non-small cell lung cancer.

The FDA has approved a 505(b) new drug application for Pemrydi RTU, the first and only ready-to-use presentation of pemetrexed (Alimta) for injection that does not require reconstitution, dilution, or refrigeration.

Brand Name:	Pemrydi RTU
Generic Name:	pemetrexed disodium
Strength:	The injectable will be available in 3 vial sizes: 100 mg/10 mL; 500 mg/mL; and 1,000 mg/mL.
Manufacturer:	Amneal Pharmaceuticals
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “Pemrydi RTU (pemetrexed disodium)” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for Pemrydi RTU (pemetrexed disodium) price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

Pemrydi RTU (Pemetrexed) Injection

Lung Cancer, Solid Tumors

Brand Name: Pemrydi RTU. Generic Name: (Pemetrexed). It is used to treat patients with malignant pleural mesotheliom.

PEMRYDI RTU® is indicated for the initial treatment, in combination with cisplatin, of patients with malignant pleural mesothelioma whose disease is unresectable or who are otherwise not candidates for curative surgery.

Brand Name:	Pemrydi RTU
Generic Name:	Pemetrexed
Strength:	• Injection: 100 mg/10 mL, 500 mg/50 mL, 1,000 mg/100 mL in single dose vials
Manufacturer:	Amneal Pharmaceuticals
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “Pemrydi RTU (Pemetrexed) Injection” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for pharma product cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

Pralsetinib Capsules

Thyroid, Lung Cancer

pralsetinib capsules,
for oral use Initial U.S. Approval: 2020

Gavreto (pralsetinib) is a medication used for the treatment of adults with metastatic RET fusion-positive non-small cell lung cancer (NSCLC) and adults with advanced or metastatic thyroid cancer.

Facts about pralsetinib-capsules

Disease Indications-Lung Cancer, Thyroid Cancer
Manufacturer-Roche Registration Limited
Usage-Oral
Medicine Approved By-European Medical Agency (EMA), Food and Drug Administration (FDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “pralsetinib capsules” based on the information you provide.

Ramucirumab Injection

Gastrointestinal, Lung Cancer

ramucirumab injection,
for intravenous use Initial U.S. Approval: 2014

Cyramza (ramucirumab) is a medication used for the treatment of advanced gastric or gastro-esophageal junction adenocarcinoma, metastatic non small cell lung cancer, and metastatic colorectal cancer.

This medicine is not (yet) part of our standard product range but we may be able to get it for you. The packaging size and strength below may vary due to product availability. Please contact us to verify price and availability.

Facts about ramucirumab injection

Disease Indications-Colorectal Cancer, Gastric Cancer, Lung Cancer
Manufacturer-Lilly
Usage-Intravenous
Medicine Approved By-European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “ramucirumab injection” based on the information you provide.

Retevmo (selpercatinib) Tablets

Chronic Disease, Lung Cancer, Solid Tumors, Thyroid

Brand Name: Retevmo. Generic Name: (selpercatinib). It is used to treat non-small cell lung cancer and thyroid cancer.

RETEVMO (reh-TEHV-moh) is used to treat certain cancers caused by abnormal RET genes in: adults with locally advanced non-small cell lung cancer (NSCLC) or NSCLC that has spread.

Brand Name:	Retevmo
Generic Name:	selpercatinib
Strength:	• Capsules: 40 mg, 80 mg
Manufacturer:	Eli Lilly and Company
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “Retevmo (selpercatinib) Tablets” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for pharma product cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

« Older Entries

Next Entries »

Contact Info

CORPORATE OFFICE:
Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi,
New Delhi:110016 India.

MOBILE / PHONE NUMBER:
M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398

EMAIL ID:
info@indianpharmanetwork.co.in

FAX NUMBER:
+91-11-26532129

Query Form For Medications

Note

We are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.

Disclaimer

“Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in is intended to provide general information about consultancy services offered by IPN and to help users access this information in a user friendly format. Certain information available on the website has been sourced from publicly available sources. While Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in believes such information to be reasonably accurate, Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in has not independently verified any of this information. All information on the IPN website is of general nature and is not a substitute for medical prescription. None of the medicines or products mentioned on the IPN website are manufactured or sold by IPN Pharma Network.

Privacy Policy

Please read the following statement to learn about our information gathering and dissemination practices in relation to our consultancy services (“Services”). Note: Our privacy policy is subject to change at any time without notice. To make sure you are aware of any changes, please review this policy periodically. By visiting the Indian Pharma Network

Health Information

“All information available on the Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in is of general nature and is not a substitute for professional medical advice by a licensed practitioner. Indian Pharma Network (IPN) does not purport to provide any medical or health-related advice, even of general nature and therefore you should not use or consult the Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in for any questions in relation to your health or medical condition.

Shipped Anti-Cancer Medicines.

Indian Pharma Network is registered medical pharmacy for Oncology Products in India. Helps you to access FDA approved Anti-Cancer-Medicines, no matter where you live. Sourcing each medicine for named patient use and overseeing every aspect of the shipping, customs and delivery. We have helped more than 6,000 patients. Send your enquiry to find the What is the cost of Anti Cancer Medicines in Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

Indian Pharma Network (IPN), New Delhi. India

Indian Pharma Network

60/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, Delhi 110016

Mobile / WhatsApp / Phone
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398

Free Customer Support
info@indianpharmanetwork.co.in
urgent@indianpharmanetwork.co.in

Lung Cancer

ORKAMBI (lumacaftor/ivacaftor) tablets

Access the best support services globally

osimertinib tablet for oral use Initial U.S. Approval: 2015

Facts about osimertinib tablet

Access the best support services globally

paclitaxel protein-bound particles for injectable suspension) (albumin-bound) for intravenous use Initial U.S. Approval: 2005

Facts about paclitaxel injection

Access the best support services globally

Palivizumab injection, for intramuscular use Initial U.S. Approval: 1998

Access the best support services globally

Brand Name: Keytruda. Generic Name: pembrolizumab Keytruda (pembrolizumab) is used to treat Urothelial Carcinoma, Breast Cancer, Colorectal Cancer, Gastric Cancer, Head and Neck Cancer, Kidney Cancer, Lung Cancer, Lymphoma, Skin Cancer

Facts about pembrolizumab injection

Access the best support services globally

Brand Name: Pemrydi RTU Generic Name: pemetrexed disodium Pemrydi RTU (pemetrexed disodium) is used to treat malignant pleural mesothelioma and non-small cell lung cancer.

Brand Name: Pemrydi RTU. Generic Name: (Pemetrexed). It is used to treat patients with malignant pleural mesotheliom.

pralsetinib capsules, for oral use Initial U.S. Approval: 2020

Access the best support services globally

ramucirumab injection, for intravenous use Initial U.S. Approval: 2014

Facts about ramucirumab injection

Access the best support services globally

Brand Name: Retevmo. Generic Name: (selpercatinib). It is used to treat non-small cell lung cancer and thyroid cancer.

Contact Info

Query Form For Medications

Note

Disclaimer

Privacy Policy

Health Information

Shipped Anti-Cancer Medicines.

Indian Pharma Network (IPN), New Delhi. India

osimertinib tablet
for oral use Initial U.S. Approval: 2015

Brand Name: Keytruda. Generic Name: pembrolizumab
Keytruda (pembrolizumab) is used to treat Urothelial Carcinoma, Breast Cancer, Colorectal Cancer, Gastric Cancer, Head and Neck Cancer, Kidney Cancer, Lung Cancer, Lymphoma, Skin Cancer

pralsetinib capsules,
for oral use Initial U.S. Approval: 2020

ramucirumab injection,
for intravenous use Initial U.S. Approval: 2014